Skip to main content
. 2022 Feb 24;15(3):283. doi: 10.3390/ph15030283

Figure 3.

Figure 3

Previous work that led to the design of the compounds presented in this work. (a) FDI-6, a thieno[2,3-b]pyridine, previously reported by Gormally et al. [8] as a direct FOXM1 inhibitor; (b) Previous FDI-6 derivatives reported by our research group [9]; (c) Compounds studied in this work.